The post-COVID surge in healthcare demand remains a huge tailwind for firms operating in the sector. This includes our latest Best Dividend Growth Stocks Model Portfolio pick, which since being added to our list (on November 19, 2021) has provided a 5.8% price return, as well as provides a decent 2.6% yield. Investors can catch this income opportunity before the stock goes ex-dividend on Monday, August 22 with a regular payout of $1.13/share.
The key to our pick’s success remains its huge portfolio of branded drugs, medical devices and innovation. New biotech discoveries as well as a portfolio of new high-tech, AI driven devices have continued to boost revenues and bring in plenty of high-margined profits.
This plus a plan spin-off has investors singing the praises of the stock and provides a long runway for continued growth.
You can check out the Best Dividend Growth Stocks Model Portfolio to explore all the stocks.
